Pharmafile Logo

Ig-Innovations

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ not the name we give the company. Born-out of the acquisition of the diagnostics division of MicroPharm, Ig has captured the skills and expertise developed during the research and development of sheep derived polyclonal antibodies for human therapy (now FDA & MHRA licensed products), diagnostics and research.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Gernos, Maesllyn, Llandysul, SA44 5LP
+44 (0)1239 858972

 Latest Content from PMHub 

PEGASUS AND UCL JOIN FORCES IN INSPIRING HEALTHY DECISIONS

Press Releases | January 31, 2017 | Inizio

Pegasus, an Ashfield company, part of UDG Healthcare plc, is proud to announce the launch of its new propriety model for planning in health – CHANGE – which was developed...

2017 Trends Reports

GSW and InVentiv Health Communications are pleased to release the 6th installment of the Trends report series, consisting of four reports: Consumer, Digital, Communications and Healthcare

Smart connections with a human touch

Simon Young, Director at Blue Latitude Health, discusses how advances in technology are influencing the future of the expert-patient relationship and why healthcare businesses must evaluate how best to support...

AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH

Through sustained partnerships between advocacy and industry, the US and Europe can overcome barriers to care.

Mental Health Patient Advocacy Groups in EU Say Strong Partnerships with Government and Industry Can Ensure Forward Progress

Press Releases | January 25, 2017 | Syneos Health®

New Report from inVentiv Health Examines Mental Health Advocacy Wish Lists and Priorities for Reform

Cool heads in a crisis?

White Papers and Resources | January 25, 2017 | Inizio

Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics

Biosimilars: Bringing patients into the conversation

White Papers and Resources | January 25, 2017 | Inizio

Published in eyeforpharma January 2017 by Mariel Metcalfe

Access and elimination: the future of DAAs in hepatitis C

White Papers and Resources | January 25, 2017 | Inizio

Published in Pharmaphorum January 2017

EphMRA One Day Meeting

White Papers and Resources | January 25, 2017 | Inizio

We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London

Video: Segmentation research

White Papers and Resources | January 25, 2017 | Inizio

Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger...